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Abstract
Background: Since aortic diameter is the most 
 significant risk factor for rupture, we sought to identify 
stress-dependent changes in gene expression to illumi-
nate novel molecular processes in aneurysm rupture. 
Materials and Methods: We constructed finite element 
maps of abdominal computerized tomography scans 
(CTs) of seven abdominal aortic aneurysm (AAA) pa-
tients to map wall stress. Paired biopsies from high- and 
low-stress areas were collected at surgery using vascular 
landmarks as coordinates. Differential gene expression 
was evaluated by Illumina Array analysis, using the whole 
genome DNA-mediated, annealing, selection, extension, 
and ligation (DASL) gene chip (n = 3 paired samples). 
Results: The sole significant candidate from this analy-
sis, Lamin A/C, was validated at the protein level, using 
western blotting. Lamin A/C expression in the inferior 
mesenteric vein (IMV) of AAA patients was compared 
to a control group and in aortic smooth muscle cells in 
culture in response to physiological pulsatile stretch. 
 Areas of high wall stress (n = 7) correlate to those  regions 
which have the thinnest walls [778 µm (585–1120 µm)] 
in comparison to areas of lowest wall stress [1620 µm 
(962–2919 µm)]. Induced expression of Lamin A/C 
 correlated with areas of high wall stress from AAAs 
but was not significantly induced in the IMV from AAA 
patients compared to controls (n = 16). Stress-induced 
expression of Lamin A/C was mimicked by exposing aor-
tic smooth muscle cells to prolonged pulsatile stretch.
Conclusion: Lamin A/C protein is specifically increased in 
areas of high wall stress in AAA from patients, but is not 
increased on other vascular beds of aneurysm patients, 
suggesting that its elevation may be a compensatory 
response to the pathobiology leading to aneurysms.
Copyright © 2015 Science International Corp.
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Introduction
Abdominal aortic aneurysm (AAA) is a chronic de-
generative vascular disease affecting 5–6% of males 
and 1–2% of females over 65 years of age [1]. Aneu-
rysmal lesions commonly manifest as focal dilatations 
of the aorta, increasing in diameter over time, ulti-
mately resulting in aortic rupture, when the strength 
of the  vessel wall fails to withstand blood pressure. 
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What we currently know about the  pathological 
 development of AAA is derived from analysis of end-
stage human biopsies [2-5], consideration of risk 
factors [6],  genome-wide association studies, and 
investigating the mechanisms involved in various ex-
perimental models of AAA [7]. 
Initiation is likely to begin with an inflammatory re-
sponse resulting in activation of matrix-destabilizing 
metalloproteinases, leading to elastin degradation 
and vascular remodeling [8-10]. Further expansion is 
accompanied by subsequent development of luminal 
thrombus resulting in mural ischemia leading to the 
 production of factors known to induce neovasculariza-
tion and thus, exacerbation of the inflammatory process 
[11]. Rarefaction of medial smooth muscle cells (SMC), 
the result of combined loss from induction of apoptotic 
cell death and reduction of proliferative expansion, con-
tributes to the production of a cell-poor, matrix-rich vas-
cular lesion that is noncompliant and structurally com-
promised. Homeostatic mechanisms of repair counter 
the disease progression, and an increase in the numbers 
of circulating endothelial progenitor cells has been doc-
umented. However, the reparative capacity of such cells 
is questionable. 
Aside from the relationship between maximal 
 aneurismal diameter and risk of rupture, we have few 
facts that inform our knowledge of the precise mech-
anism of rupture, currently the 13th most common 
cause of sudden death in the world [12]. In previously 
published work, we identified the differential expres-
sion and pathological features of aneurysm rupture, 
by comparing tissue biopsies taken proximal to the 
rupture site to biopsies collected distal to the rup-
ture. Our data suggested that medial neovascular-
ization preceded rupture and that this local increase 
in small vessels potentially weakened the vessel wall, 
leading to rupture [13]. To gain a further understand-
ing of the biological changes occurring in the vessel 
wall prior to rupture, this study aims to identify stress- 
dependent modulation in gene expression. 
Methods
Patients 
The collection of paired AAA biopsies were carried out 
prospectively and conducted according to the principles of 
the declaration of Helsinki and approved by the local ethics 
committee (ref 09/H0803/0011). Patients scheduled for elec-
tive open aneurysm repair were recruited and biopsies col-
lected between January 2008 and December 2009. Patients 
undergoing emergency surgery and those suitable for endo-
vascular repair were excluded. In addition, patients who had 
had previous surgery or endovascular repair, patients with 
inflammatory aneurysms and additional connective tissue 
disorders were also excluded. Inferior mesenteric vein (IMV) 
samples were collected between December 2008 and Janu-
ary 2010. A segment of IMV was obtained from 16 patients 
with AAA (> 5 cm in diameter) at the time of open AAA repair. 
Control samples were obtained from patients undergoing left 
hemi-colectomy for benign colonic pathology (confirmed by 
histology). The site of IMV harvesting and specimen size was 
consistent across both groups. AAA patients were excluded if 
they had inflammatory AAA, known malignancy, active coli-
tis, or had a previous hemi-colectomy. Control patients were 
excluded if they had active inflammatory processes, were on 
current steroid therapy, prior chemotherapy, or an AAA visi-
ble on preoperative imaging. Written informed consent was 
obtained from all patients and consent forms received local 
ethics committee approval (ref 08/H0803/210). IMV samples 
were obtained from the colonic mesentery, irrigated with 
saline, and stripped of accessory connective tissue. Samples 
were immediately snap-frozen in liquid nitrogen and stored 
at -80oC until protein analysis.
Biopsy Localization and Sample Harvest 
Full thickness biopsies were obtained during elective open 
repair. Coordinates of regions of highest and lowest wall stress 
were identified on the Finite Element Analysis (FEA) model by 
measuring the distance and clock position on the finite ele-
ment mesh from the proximal starting point (the level of the 
first CT slice imported into the FEA software). Measurement 
was performed by using the distance measurement tool 
in the FEA software interface. A detailed, 3D reconstruction 
image of the aorta including the major visceral branches 
was performed (3mensio 3D imaging workstation, 3mensio 
Medical Imaging B.V., Bilthoven, The Netherlands). The coor-
dinates of regions of interest were localized according to the 
distance from adjacent visceral branches as determined from 
the FEA software. Intraoperatively, high and low wall stress 
regions were marked (according to the above distance) on 
the aneurysm surface  before aortic clamping. Full thickness 
biopsies were obtained from the marked regions once the sac 
was opened. The samples were washed in saline to  remove 
any attached intraluminal thrombus (ILT). Mechanical scrap-
ping of ILT was avoided and not necessary as washing was 
sufficient to remove adjacent ILT as confirmed by microscopic 
examination. The proximity of areas of high wall stress in rela-
tion to maximal aortic diameter (MAD) was assessed visually 
by inspecting wall stress maps and corresponding computed 
tomography images.
Wall Thickness Measurements
All samples were measured in saline at room temperature 
immediately after biopsy. The samples were washed gently to 
remove excess ILT with no mechanical scraping. Wall thickness 
was measured by computer assisted micrometry using the Ax-
ioVs40 micro telescope system (Carl Zeiss Imaging Solutions, 
Germany) at 1-mm intervals to allow for aneurysm wall het-
erogeneity and a mean value for each specimen was obtained.
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by  Quantitative Real-Time (QRT)-PCR using TaqMan probes 
( Assays-on-Demand™ Gene Expression Products,  Applied 
Biosystems, UK), with the carboxyfluorescein fluorescent dye 
6-FAM as the 5’-fluorophore and nonfluorescent quencher 
(NFQ) at the 3’-end of the probe. QRT-PCR reaction mixtures 
for each sample were 50 µl, containing 25 µl of 2× TaqMan 
Universal Master Mix (without AmpErase® UNG), 22.5 µl cDNA 
template, and 2.5 µl of 20× target assay mix. Each sample was 
run in triplicate and for all reactions, negative controls were 
run with no template present. In addition, total RNA from 
patient samples was used for sham reverse transcription re-
actions with no reverse transcriptase present and then sub-
jected to standard PCR using 18S rRNA primers to verify that 
no amplification was produced. QRT-PCR was carried out 
using an Mx4000 Multiplex Quantitative PCR System. The 
PCR cycle started with an initial 10 min denaturation step at 
95°C, followed by 40 cycles of shuttle heating at 95°C for 
15 s and 60°C for 1 min. The associated Mx4000 software 
was used to analyze the data and determine the threshold 
count (Ct). Ct was determined for the target genes and 18S 
rRNA. 18S rRNA was chosen as the endogenous control to 
which we normalized our specimens. Preliminary valida-
tion experiments verified that the efficiencies of target gene 
amplification and the efficiency of the mean value of trans-
ferrin receptor and TATA box-binding protein rRNA ampli-
fication to be approximately equal; therefore, we validated 
that the target gene:mean endogenous control rRNA ratio 
could be calculated using the ΔCt method. For each sample, 
Cttarget gene and Ctmean endogenous control rRNA were de-
termined, and ΔCt = Cttarget gene – Ctmean endogenous rRNA. 
The relative level of the target gene normalized to transfer-
rin receptor and TATA box-binding protein was determined 
by calculating 2-∆Ct. 
Western Blotting 
Total cell lysates (30 µg protein) were separated on an SDS-
PAGE (10–12% running gel, 4% stacking gel. Bio-Rad, Herts, 
UK). Protein was then transferred to PVDF membrane (Milli-
pore, Watford, UK). Blocking was performed overnight at 4°C 
in Tris-buffered saline (TBS) plus 5% non-fat dry milk. Blots 
were incubated with primary antibodies as follows: Lamin A/C 
(Cell  Signaling, clone 4C11 at 1:1000) and Lamin A ( Santa Cruz 
Biotech, clone C20 at 1:500) overnight at 4°C in TBS with 
0.05% Tween-20 and 5% non-fat dried milk followed by in-
cubation with HRP- conjugated secondary antibody (1:2000) 
(New England Biolabs, Herts, UK) for 45 minutes. Immunode-
tection was accomplished using chemiluminescence (Super 
 Signal-HRP, Pierce Chemical Corp., Chester, UK).  Detected 
bands were scanned on a calibrated densitometer (GS-800, 
Bio-Rad, Herts, UK) and quantified using Quantity One image 
analysis software (Bio-Rad). The densitometry of each band 
was normalized to the abundance of β-actin (ab8227, Abcam, 
Cambridge, UK) or β-tubulin (ab21057, Abcam, Cambridge, 
UK) staining using Image J (NIH) software.
Stretch Experiments with Human Aortic Smooth  
Muscle Cells
Early passages (2–3) human aortic smooth muscle cells 
(AoSMC) (PromoCell, Heidelberg Germany) were plated in 
Finite Element Analysis 
FEA is a computational modelling technique used by the 
engineering industry to simulate wall stress distribution in 
complex structures. This method has recently been used to 
predict the risk of rupture in individual AAAs in experimental 
studies. FEA takes into account detailed aneurysm morphol-
ogy, hemodynamic forces, and mechanical properties of the 
AAA to determine the mechanical stress distribution. A de-
tailed 3D model of each AAA is constructed from preoperative 
computed tomography (CT) imaging to provide a wall stress 
map that is unique for each patient [14]. Since arterial walls 
exhibit nonlinear behavior and undergo large strains, a finite 
strain constitutive equation based on the model derived by 
Raghavan and Vorp [15] specifically suited for AAA wall was 
used. Multi-component wall models were built to include 
the aortic wall and ILT. Appropriate material properties for 
each component were used. Finite element analyses were 
performed using ADINA (ADINA R&D Inc., Watertown, Massa-
chusetts, USA) to determine patterns and values of wall stress 
within the affected aorta. 
Gene Array Analysis 
Tissue biopsies for RNA isolation were transported from the 
theatre in RNA-stabilizing solution (Ambion, Inc., UK) and pro-
cessed immediately for total RNA isolation using an RNeasy 
Mini Fibrous Kit (Qiagen, UK) according to the manufacturer’s 
recommendations. Briefly, 50 mg of tissue is ground to a fine 
powder in liquid nitrogen, and the powder then homoge-
nized with lysis buffer using a rotor homogenizer (IKA, Werke 
GmbH, Germany). The concentration and purity of each sam-
ple (ng/µl) was determined by NanoDrop™ ND-3300 (Thermo 
Scientific, UK) and Agilent BioAnalyser, Agilent Technologies, 
UK), respectively. 
The gene expression of these samples were carried out at 
The Genome Centre, Queen Mary, University of London using 
the whole-genome complementary DNA-mediated, anneal-
ing, selection, extension, and ligation (DASL) array Human 
Ref-8 vs. 3.0 Bead Chips (Illumina, San Diego, CA, USA). This 
chip includes 24,526 probes targeting 18,401 genes. In brief, 
total RNA was converted into cDNA using the biotinylated 
random nonamers, oligo-deoxythymidine 18 primers, and 
Illumina-supplied reagents, according to the manufacturer’s 
protocol. The biotinylated cDNA was then annealed to assay 
oligonucleotides and bound to streptavidin-conjugated para-
magnetic materials to select RNA at 55°C for 18 hours to the 
array, followed by washing and staining with streptavidin and 
conjugation to cyanin 3. Post-hybridization, the chips were 
scanned using the BeadArray™ Reader system (Illumina, UK). 
Gene expression data were normalized using quantile nor-
malization and log-transformed. Statistical analysis and hier-
archical clustering were performed using the Genespring GX 
9 (Agilent Technologies, UK).
Quantitative Real-Time Polymerase Chain Reaction 
(QRT-PCR)
LMNA expression was validated by QRT-PCR using TaqMan™ 
Gene expression Assays on Demand (Applied Biosystems, 
UK) and the Mx4000 Multiplex Quantitative PCR System 
(Stratagene, UK). The mRNA levels of LMNA was  determined 
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between wall thickness (in both high and low stress 
regions) and maximal aortic diameter (r = 0.2, r = 0.6), 
respectively. 
Gene Array Analysis Identifies Lamin A/C as the Most 
Significant Stress-Dependent Candidate Gene
Three of the seven paired biopsies provided RNA 
isolates of sufficient quality (RIN >9) to proceed to 
gene array analysis. A total of 125 genes (71 upregu-
lated and 54 downregulated) had a greater than 2-fold 
difference of expression (p < 0.05) in the high wall 
stress biopsy compared to the low wall-stress biopsy 
(see Supplementary Table 1). Supplementary Table 2 
shows the gene ontology processes associated with 
the genes identified. However, when the Benjamini- 
Hochberg multiple testing correction was applied to 
these data, only Lamin A/C was the sole candidate 
which was differentially expressed (2.1-fold change, 
n = 3, p = 0.02). Differential gene expression was val-
idated using QRT-PCR using the transferrin receptor 
and TATA-box binding protein as reference genes 
(2.83-fold change, n = 3, p < 0.05).
Lamin A/C Protein is Significantly Increased  
in Regions of High Walls Stress
To establish if the differential expression of Lamin 
A/C was reiterated at the protein level, we analyzed 
relative protein abundance by western blotting. We 
found a two-fold induction of Lamin A/C protein 
(0.99  ± 0.28 vs. 1.88 ± 0.72, n=3, p < 0.05) in aortic 
biopsies from regions of high wall stress compared 
to low wall stress (Figure 2). Western blotting data of 
Lamin A/C for each of the three samples is included in 
the panel below the histogram.
Lamin A/C Protein Concentration is Not Elevated In 
Non-Aneurysmal Vascular Beds of AAA Patients
Accruing evidence supports the idea that ear-
ly aneurismal changes can also be manifest in vas-
cular beds without signs of dilatation. Analysis of 
non-aneurysmal vessels from AAA patients allow 
us to explore the question as to whether eleva-
tion of Lamin A/C expression represents an early 
 systemic event. We measured the protein abundance 
in the IMV of AAA patients removed following sur-
gery for other conditions and compared the level of 
completed growth medium (PromoCell, Heidelberg, Germa-
ny) on six-well Bioflex plates coated with collagen Type I (Fl-
excell International Corporation, NC, USA). Confluent AoSMC 
were then subjected to no stretch or cyclic sine wave stretch 
stress using stretch equipment [Flexcell FX-5000T Compres-
sion System (Dunn Labortechnik, Ashbach, Germany)] at 37oC 
and 5% CO2 for different periods of time up to 20 h. Following 
stretch stress, cells were allowed to relax for 20 h, and soluble 
proteins were isolated at times (as indicated). Lamin A/C and 
Prelamin protein expression was measured by western blot-
ting using antibodies of interest. Actin was used as a loading 
control. Data are the mean ± SD (n = 3 independent experi-
ments at each data point, p* < 0.05).
Statistical Analysis
Data are presented as mean ± SD, unless otherwise stat-
ed. Analysis of western blot data was by one-way ANOVA 
followed by a Bonferronni’s post-hoc test for multiple com-
parisons. The Benjamini-Hochberg post-hoc test for multiple 
measures was applied to the differential gene expression 
data following normalization. Wall thickness was recorded 
as median and interquartile ranges. Correlation between 
variables was performed using Spearman’s correlation. 
Significance was identified as a p value of less than 0.05. 
Statistical analysis was performed using GraphPad Prism, 
version 4.0.
Results
Regions of High Stress Correlate with Thinning of the 
Aortic Wall
Patient-specific wall stress computation was per-
formed on ten patients. It was not possible to obtain 
paired biopsies from three patients (posterior loca-
tion in one, near proximal graft anastamosis in two). 
Seven paired samples were obtained (five males and 
two females) from regions of highest and lowest wall 
stress (Figure 1). The seven patients used in this study 
were all prescribed HMG CoA reductase inhibitor 
drugs and anti-hypertensive treatments. They were 
all well nourished, but none were clinically obese. 
Measurement of seven paired biopsies showed that 
regions of high wall stress had an approximately two-
fold reduction in full wall thickness. The seven pa-
tients biopsied had a mean age of 66 (60–82 years) 
and a median maximal aortic diameter of 60 (51–70 
mm). 
We found that the median and interquartile range 
(IQR) for wall thickness from areas of low wall stress 
were 1620 (962–2912 µm) thick, compared to 778 
(585–1120 µm) in regions of high wall stress. No obvi-
ously thickened atheromatous plaques were encoun-
tered during measurement. No correlation was found 
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expression to IMV from control patients without AAA. 
Figure 3 shows no significant difference between the 
abundance of Lamin A/C from IMV of patients with 
AAA compared to controls (3.32 ± 2.17 vs. 3.94 ± 1.12, 
n = 16, p = NSD).
Physiological Pulsatile Stretch of SMC in Culture  
Induces a Time-Dependent Elevation of Lamin A/C  
and Prelamin A Expression 
Since SMC of the normal human vasculature are sub-
jected to constant pulsatile stretch, we explored wheth-
er expression of Lamin A/C could be influenced by 
pulsatile stretch in vitro. We seeded SMC onto Flexcell™ 
plates, and once the cells had reached confluence, the 
complete growth medium was changed and the cul-
tures subjected to pulsatile stretch at 15% elongation, 1 
Hz for 20 hours, followed by 20-hours relaxation. Figure 
4 shows western blotting data from protein lysates pre-
pared at indicated times, confirming that the expression 
of [A] Lamin A/C and [B] Prelamin A steadily increased, 
reaching a peak at 24 hours after the start of the experi-
ment (approximately five-fold higher than basal levels), 
4 hours following the beginning of relaxation. Following 
a 20-hour period of relaxation, Lamin A/C expression 
was down to normal resting state and the Prelamin A 
remained significantly elevated (approximately 3-fold 
increased) at this time (n = 3, *p < 0.05, **p < 0.01).
Discussion
A number of human aneurysm gene expression 
profile arrays have previously been reported [16-19] 
and analysis of paired biopsies, using the presence 
or absence of thrombus over the aneurysmal wall 
as a discriminator, identified MMP-1, -7, -9, and -12 
as being differentially expressed [20]. However, this 
is the first time that wall stress has been used to dis-
criminate paired biopsies for gene expression profil-
ing.  Identification of stress-dependent expression 
of Lamin A/C in AAA represents the first time that at-
tention has been drawn to the nuclear lamina in this 
 degenerative vascular pathology. 
Differential gene array analyses notoriously re-
veal many divergent candidate genes. Since fol-
lowing rigorous statistical adjustment for multiple 
measures, Lamin A/C was revealed as our sole can-
didate, it is most likely that either our selection cri-
teria were overly stringent, or we have too small a 
sample. If the Benjamini-Hochberg post-hoc test for 
multiple comparison is not applied to the array data, 
reducing the level of statistical stringency, a broad 
register of differential genes is generated (see Sup-
plementary Table 3). Using a two-fold change as a 
cut-off and a p value less than 0.005 we identify the 
expression of seventy one genes which are induced 
and fifty four reduced. This gene array  represents 
molecules that play a role in the immune response, 
regulation of cell growth, gene expression, angio-
genesis, cell matrix synthesis, degradation, and 
inflammation. Two other candidates have been 
shown to have a particular relevance to aneurysm 
biology: ADAMTS2, an extracellular matrix protease 
known to be involved in Ehlers-Danlos syndrome 
[21], and also identified as having a role in arterial 
Figure 1. Schematic diagram illustrating experimental design. CT scans of participating patients (1) were converted into 3D recon-
structions (2) and the Diacom™ files analyzed by FEA (3) to provide a three dimensional stress distribution of the AAA. Red color 
corresponds to highest wall stress whilst blue for lowest wall stress. The FEA were then overlaid onto the 3D CT in the theatre, and 
the biopsies harvested (4). Of 11 patients recruited, seven paired biopsies were harvested for analysis. In four patients one or other 
of the biopsy sites were not in an accessible location. AAA = abdominal aortic aneurysm; FEA = finite element analysis.
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The identification of Lamin A/C as a stress-induced 
candidate gene is consistent with several aspects of 
the pathobiology of this disease. Lamins form a thin 
(20 nm) intermediate filament meshwork which lines 
the nucleoplasmic face of the nuclear envelope (NE). 
tortuosity syndrome [22]; and prostaglandin E2 re-
ceptor, previously shown to have a role in aneurysm 
biology [23] and recently reintroduced as a poten-
tial therapeutic candidate for use in cardiovascular 
inflammation.
Figure 3. Lamin A/C is not induced in other vascular beds of 
aneurysm patients. Protein abundance of Lamin A/C relative to 
β-tubulin in the inferior mesenteric vein of control (no aneurysm) 
and aneurysmal patients shows no significant difference. Histo-
gram represents data as mean ± SD (n = 16), with a representa-
tive example of four samples from each group as western blot-
ting gel data in panel below; NSD = not significantly different.
Figure 2. Lamin A/C protein abundance is differentially induced 
in human aneurysmal biopsies from areas of high wall-stress. 
Histogram shows relative abundance of Lamin A/C from protein 
lysates of aneurysmal biopsies from areas of low wall stress (LWS) 
and high wall stress (HWS) relative to β-tubulin. Western blotting 
gel data for each of three patients is shown in the panel below. 
Data represent mean ± SD (n = 3, p < 0.05).
Figure 4. Stretch-dependent effects on Lamin A/C and Prelamin A in human aortic smooth muscle cells. Human aortic smooth 
muscle cells (SMC) were grown to confluence and following a change of complete medium were then exposed to 20 hours stretch 
(15% elongation, 1 Hz) followed by 20-hours relaxation. Protein lysates were prepared at 6, 12, 20, 24, 32, and 40 hours. Panel A. Time-
course of changes in Lamin A/C expression. Panel B. Time-course of changes in Prelamin A expression relative to β-actin in SMCs. 
Data are representative of three experiments (*p < 0.05, **p < 0.01).
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40] or atypical Werner’s Syndrome [41], and dilated 
cardiomyopathy [42], Charcot-Marie-Tooth disease 
Type 1 [43], Dunnigan-type familial partial lipodys-
trophy [44], mandibuloacral dysplasia [45], and re-
strictive dermopathy [46]. A number of the clinical 
features of these diseased phenotypes are sugges-
tive of accelerated aging, and studies in vitro have 
shown that overexpression of mutant and wild-type 
Lamin A accelerates telomere shortening and repli-
cative senescence [47]. We and others have shown 
that there is an elevated number of circulating pro-
genitor cells and that the telomeres of such cells are 
shorter in comparison to age matched controls, sug-
gesting that AAAs represent focal lesions of acceler-
ated aging [48, 49]. This being so, the demonstration 
of focal induction of Lamin A/C expression warrants 
investigative consideration as a potential player 
in  generating these chronic degenerative vascular 
lesions.
Apoptosis, programmed cell death, plays a funda-
mental role in aneurysm development [50]. In a re-
cent study where aneurysm formation was perturbed 
by elevation of plasma high-density lipoprotein 
concentration, we show that site-specific apoptosis 
was inhibited [51]. In cells programmed to die, the 
caspase-dependent degradation of Lamins has been 
recognized as a prelude to nuclear destruction [52]. 
Recent work suggests that not only is Lamin degrada-
tion a feature of apoptosis but that failure to  correctly 
assemble nuclear lamina is a trigger for apoptosis 
[53]. The overexpression of Lamin A/C that we ob-
serve in the high wall-stress regions of AAA may rep-
resent a mechanism to counter apoptotic induction, 
but further work is needed to support this idea.
The predominant weakness of these experiments 
is the small number of paired biopsies available for 
analysis. With an increase in application of endovas-
cular repair, the numbers of elective open repair are 
reduced. To address this issue, we are archiving addi-
tional material over a longer period of time for further 
studies.
We have identified an increase in Lamin A/C pro-
tein expression as a wall stress-dependent change ob-
served in AAAs. Since these changes are not observed 
in non-aneurysmal vascular beds of AAA patients, it 
is most likely to be a compensatory response to the 
accelerated ageing process that is  characteristic of 
The nuclear lamina is associated with the inner NE 
and the underlying chromatin and also provides an 
anchoring point for the nuclear pore complex. In 
mammalian somatic cells, Lamins A and C (Lamin 
A/C) are generated by differential splicing of a sin-
gle gene (LMNA). These products differ by virtue of 
a unique C-terminal extension, 99 amino acids for 
Lamin A and 6 for Lamin C [24]. Lamin A goes through 
multiple steps of post-translational processing at its 
C-terminal CaaX motif, involving 3–4 enzymes. First, 
a farnesyl moiety is added to cysteine by farnesyl 
transferase 1. The cleavage of the last three amino ac-
ids (aaXing) by either Rce1 or ZmpSte2 occurs. Then, 
the C-terminal cysteine is carboxymethylated by iso-
prenylcysteine carboxymethyltransferase, resulting 
in carboxymethylated Prelamin A. Within 90 minutes 
of synthesis, ZmpSte24 cleaves Prelamin A (74 kDa), 
14 amino acids upstream of the C-terminus, resulting 
in mature Lamin A (72 kDa) [25-30].
Mechanotransduction, the phenomenon by which 
cells respond to applied force, is critical to several phys-
iological and pathological processes [31]. The exact 
mechanisms which govern how forces can  influence 
biological processes have not been  determined, but 
putative direct force effects on the genome must 
require transduction through the  nuclear lamina. 
Lamins not only provide a nuclear scaffold of inter-
mediate filaments important in mechanotransduc-
tion but are also found in the nucleoplasm, being 
part of the intranuclear reticulum, thought to play an 
important role in the maintenance of nuclear struc-
tural integrity, in DNA replication, transcriptional 
regulation, and apoptosis [32-34]. Expression and ac-
cumulation of a mutant form of Lamin A associated 
with Hutchinson-Gilford Progeric Syndrome (HGPS) 
(Lamin A D50) causes changes in the nuclear lami-
na network organization [35] and an increase in the 
accumulation of Prelamin and nuclear stiffness [36] 
with implications for mechanisms of normal ageing 
and atherosclerotic vascular changes. Recent studies 
have demonstrated that accumulation of Prelamin 
accelerates normal smooth muscle cell aging [37].
Mutation in the LMNA gene have been responsi-
ble for at least nine classes of disorders, collectively 
called laminopathies, including muscular dystro-
phies Emery-Dreifuss and limb-girdle muscular dys-
trophy, Type 1B [38], in accelerated aging, HGPS [39, 
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of Lamin A/C in vitro will facilitate more molecular 
analyses in the  future.
Acknowledgements 
The authors would like to thank Dr. Ken Laing for 
his helpful advice on the gene array experiment and 
for the bioinformatics support necessary for analy-
sis. Thanks to Jan Polonieki for statistical advice and 
our thanks to all the patients who consented to col-
lection and donation of their tissue for this study. 
The authors are grateful to Zhuo Cheng and Anenta 
Ratneswaren who assisted in the finite element anal-
ysis presented in this study. This work was support-
ed by an EU FP7-HEALTH integrated project grant 
(Fighting Aneurysmal Disease), agreement number 
200467. AM was the recipient of a Royal College of 
Surgeons Fellowship.
Conflict of Interest
The authors have no conflicts of interest relevant 
to this publication.
Comment on this Article or Ask a Question 
aneurysm pathobiology. The reason that induction 
of expression of Lamin A/C may be desirable and 
represent a homeostatic mechanism to counter the 
degenerative progression of the vessel may relate to 
the ability of Lamin A/C to protect chromatin struc-
ture and prevent apoptosis. Although it will be chal-
lenging to develop Lamin A/C as a molecule of any 
clinical use in the management/or treatment of AAA, 
our findings support the validity of this experimen-
tal design as a means of further discovery. Larger 
numbers of patients are required to allow us to gain 
a significant number of good quality paired samples 
for similar analysis. However, since aneurysms share 
common features of biology with advanced aging, 
and treatment with farnesyltransferase inhibitors has 
the potential to perturb this process in vitro and in 
vivo [54, 55], these drugs may provide an interesting 
new therapeutic  strategy for management of AAA 
growth. Further investigation of target genes, such 
as Lamin A/C, that impact on mechanotransduction 
may have importance in thoracic aortic aneurysms, 
since although  the etiology of these pathologies 
differs from  abdominal aortic aneurysms the role of 
mechanodysfunction on molecular changes in cell 
biology  may  be  similar [56-58]. Such ideas warrant 
further  investigation. The ability to mimic induction 
1. Collaborative Aneurysm Screening Group. 
A comparative study of the prevalence of 
abdominal aortic aneurysms in the Unit-
ed Kingdom, Denmark and Australia. J 
Med Screen. 2001;8:46-84. DOI: 10.1136/
jms.8.1.46
2. Allaire E, Hasenstab D, Kenagy RD, Starcher 
B, Clowes MM, Clowes AW. Prevention of 
aneurysm development and rupture by 
local overexpression of plasminogen acti-
vator inhibitor-1. Circulation. 1998;98:249-
255. DOI: 10.1161/01.CIR.98.3.249
3. Curci JA, Liao S, Huffman MD, Shapiro SD, 
Thompson RW. Expression and localization 
of macrophage elastase (matrix metallo-
proteinase-12) in abdominal aortic aneu-
rysms. J Clin Invest. 1998;102:1900-1910. 
DOI: 10.1172/JCI2182
4. Freestone T, Turner RJ, Coady A, Higman 
DJ, Greenhalgh RM, Powell J. Inflamma-
tion and matrix metalloproteinase’s in the 
enlarging abdominal aortic aneurysm. Ar-
terioscler Thromb Vasc Biol. 1995;15:1145-
1151. DOI: 10.1161/01.ATV.15.8.1145
5. Wilson WR, Anderton M, Schwalbe 
EC, Jones JL, Furness PN, Bell PR, et al. 
Matrix metalloproteinase’s-8 and -9 are  
increased at the site of abdominal aortic 
 aneurysm rupture. Circulation. 2006;113: 
438-445. DOI: 10.1161/CIRCULATIONA-
HA.105.551572
6. Lederle FA, Johnson GR, Wilson SE, Chute 
EP, Hye RJ, Makaroun MS, et al. The an-
eurysm detection and management 
study screening program: Validation co-
hort and final results. Arch Intern Med. 
2000;160:1425-1430. DOI: 10.1001/
archinte.160.10.1425
7. Tsui JC. Experimental models of abdom-
inal aortic aneurysms. Open Cardiovasc 
Med J. 2010;4:221-230. DOI: 10.2174/ 
1874192401004010221
8. Nordon IM, Hinchliffe RJ, Loftus IM, Thomp-
son MM. Pathophysiology and epidemiol-
ogy of abdominal aortic aneurysms. Nat 
Rev Cardiol. 2011;8:92-102. DOI: 10.1038/
nrcardio.2010.180
9. Shimizu K, Mitchell RN, Libby P. Inflam-
mation and cellular immune responses in 
abdominal aortic aneurysms. Arterioscler 
Thromb Vasc Biol. 2006;26:987-994. DOI: 
10.1161/01.ATV.0000214999.12921.4f
10. Shin IS, Kim JM, Kim KL, Jang SY, Jeon ES, 
Choi SH, et al. Early growth response fac-
tor-1 is associated with intraluminal throm-
bus formation in human abdominal aortic 
aneurysm. J Am Coll  Cardiol. 2009;53:792-
799. DOI: 10.1016/j.jacc. 2008.10.055
11. Martinez-Pinna R, Madrigal-Matute J, Tarin C, 
Burillo E, Esteban-Salan M, Pastor- Vargas C, 
et al. Proteomic analysis of intraluminal 
thrombus highlights complement activa-
tion in human abdominal aortic aneurysms. 
Arterioscler Thromb Vasc Biol. 2013;33:2013-
2020. DOI: 10.1161/ATVBAHA.112.301191
12. Filardo G, Powell JT, Martinez MA, Ballard 
DJ. Surgery for small asymptomatic ab-
dominal aortic aneurysms. Cochrane Da-
tabase Syst Rev. 2012;3:CD001835. DOI: 
10.1002/14651858.cd001835.pub3
13. Choke E, Thompson MM, Dawson J,  Wilson 
WR, Sayed S, Loftus IM, et al.  Abdominal 
References
AORTA, October 2015            Volume 3, Issue 5:152-166
Original Research Article             160
aortic aneurysm rupture is associated 
with increased medial neovascularization 
and overexpression of proangiogenic 
cytokines. Arterioscler Thromb Vasc Biol. 
2006;26:2077-2082. DOI: 10.1161/01.ATV. 
0000234944.22509.f9
14. Xu XY, Borghi A, Nchimi A, Leung J, Gomez 
P, Cheng Z, et al. High levels of 18-FDG up-
take in aortic aneurysm wall are associated 
with high wall stress. Eur J Vas Endovasc 
Surg. 2010;39:295-301. DOI: 10.1016/j.
ejvs.2009.10.016
15. Raghavan ML, Vorp DA. Toward a biome-
chanical tool to evaluate rupture potential 
of abdominal aortic aneurysm: Identifica-
tion of a finite strain constitutive model 
and evaluation of its applicability. J Bio-
mech. 2000;33:475-482. DOI: 10.1016/
S0021-9290(99)00201-8
16. Lenk GM, Tromp G, Weinsheimer S, 
 Gatalica Z, Berguer R, Kuivaniemi H. Whole 
genome expression profiling reveals a 
significant role for immune function in 
human  abdominal aortic aneurysms. 
BMC Genomics. 2007;8:237-242. DOI: 
10.1186/1471-2164-8-237
17. Choke E, Thompson MM, Jones A, Torsney 
E, Dawson J, Laing K, et al. Gene expres-
sion profile of abdominal aortic aneurysm 
rupture. Ann NY Acad Sci. 2006;1085:311-
314. DOI: 10.1196/annals.1383.007; 
10.1196/annals.1383.006
18. Tung WS, Lee JK, Thompson RW. Simulta-
neous analysis of 1176 gene products in 
normal human aorta and abdominal aor-
tic aneurysms using a membrane-based 
complementary DNA expression array. 
J Vasc Surg. 2001;34:143-150. DOI: 10.1067/
mva.2001.113310
19. Tilson MD, Fu C, Xia SX, Syn D, Yoon Y, 
 McCaffrey T. Expression of molecular 
messages for angiogenesis by fibroblasts 
from aneurysmal abdominal aorta ver-
sus dermal fibroblasts. Int J Surg Invest. 
2000;1:453-457. PMID: 11341602 
20. Kazi M, Zhu C, Roy J, Paulsson-Berne G, 
Hamsten A, Swedenborg J, et al. Difference 
in matrix-degrading protease expression 
and activity between thrombus-free and 
thrombus-covered wall of abdominal aor-
tic aneurysm. Arterioscler Thromb Vasc 
Biol. 2005;25:1341-1346. DOI: 10.1161/01.
ATV.0000166601.49954.21 
21. Colige A, Nuytinck L, Hausser I, van Essen 
AJ, Thiry M, Herens C, et al. Novel types 
of mutation responsible for the dermato-
sparactic type of Ehlers-Danlos syndrome 
(Type VIIC) and common polymorphisms 
in the ADAMTS2 gene. J Invest Dermatol. 
2004;123:656-663. DOI: 10.1111/j.0022-
202X.2004.23406.x
22. Gardella R, Zoppi N, Assanelli D, Muiesan ML, 
Barlati S, Colombi M. Exclusion of candidate 
genes in a family with arterial tortuosity syn-
drome. Am J Med Genet A. 2004;126A:221-
228. DOI: 10.1002/ajmg.a.20589
23. Bayston T, Ramessur S, Reise J, Jones KG, 
Powell JT. Prostaglandin E2 receptors in 
abdominal aortic aneurysm and human 
aortic smooth muscle cells. J Vasc Surg. 
2003;38:354-359. DOI: 10.1016/S0741-
5214(03)00339-2
24. Lin F, Warman HJ. Structural organiza-
tion of the human gene encoding nu-
clear lamin A and nuclear lamin C. J Biol 
Chem.1993;268:16321-16326. PMID: 8344919 
25. Gerace L, Comeau C, Benson M. Organi-
zation and modulation of nuclear lamina 
structure. J Cell Sci Suppl. 1984;1:137-160. 
DOI: 10.1242/jcs.1984.Supplement_1.10
26. Varela I, Cadiñanos J, Pendás AM, Guti-
érrez-Fernández A, Folgueras AR, Sán-
chez LM, et al. Accelerated ageing in 
mice deficient in Zmpste24 protease is 
linked to p53 signalling activation. Na-
ture. 2005;437:564-568. DOI: 10.1038/na-
ture04019
27. Bergo MO, Gavino B, Ross J, Schmidt WK, 
Hong C, Kendall LV, et al. Zmpste24 defi-
ciency in mice causes spontaneous bone 
fractures, muscle weakness, and a prelamin 
A processing defect. Proc Natl Acad Sci 
USA. 2002;99:13049-13054. DOI: 10.1073/
pnas.192460799
28. Corrigan DP, Kuszczak D, Rusinol AE, Thewke 
DP, Hrycyna CA, Michaelis S, et al. Prelamin 
A endoproteolytic processing in vitro by re-
combinant Zmpste24. Biochem J. 2005;387: 
129-318. DOI: 10.1042/BJ20041359
29. Weber K, Plessmann U, Traub P. Matura-
tion of nuclear lamin A involves a specific 
 carboxy-terminal trimming, which removes 
the polyisoprenylation site from the pre-
cursor; implications for the structure of the 
nuclear lamina. FEBS Lett. 1989;257:411-
414. DOI: 10.1016/0014-5793(89)81584-4
30. Beck LA, Hosick TJ, Sinensky M. Isoprenyla-
tion is required for the processing of the 
lamin A precursor. J Cell Biol. 1990;110:1489-
1499. DOI: 10.1083/jcb.110.5.1489
31. Shyu KG. Cellular and molecular effects of 
mechanical stretch on vascular cells and car-
diac myocytes. Clin Sci (Lond). 2009;116:377-
389. DOI: 10.1042/CS20080163
32. Fuchs E, Weber K. Intermediate filaments: 
Structure, dynamics, function and disease. 
Annu Rev Biochem. 1994;63:345-382. DOI: 
10.1146/annurev.bi.63.070194.002021
33. Lammerding J, Schulze PC, Takahashi T, 
Kozlov S, Sullivan T, Kamm RD, et al. Lamin 
A/C deficiency causes defective nuclear 
mechanics and mechanotransduction. 
J Clin Invest. 2004;113:370-378. DOI: 
10.1172/JCI200419670
34. Wilson KL, Zastrow MS, Lee KK. Lamins and 
disease: Insights into nuclear infrastruc-
ture. Cell. 2001;104:647-650. DOI: 10.1016/
S0092-8674(02)01452-6; 10.1016/S0092-
8674(01)00261-6
35. Goldman RD, Shumaker DK, Erdos MR, 
Eriksson M, Goldman AE, Gordon LB, et al. 
Accumulation of mutant lamin A causes 
progressive changes in nuclear architecture 
in Hutchinson-Gilford progeria syndrome. 
Proc Natl Acad Sci USA. 2004;101:8963-
8968. DOI: 10.1073/pnas.0402943101
36. Dahl KN, Scaffidi P, Islam MF, Yodh AG, 
 Wilson KL, Misteli T. Distinct structural and 
 mechanical properties of the nuclear lam-
ina in Hutchinson-Gilford progeria syn-
drome. Proc Natl Acad Sci USA. 2006; 103: 
10271-10276. DOI: 10.1073/pnas.0601058103
37. Ragnauth CD, Warren DT, Liu Y, McNair R, Ta-
jsic T, Figg N, et al. Prelamin A acts to accel-
erate smooth muscle cell senescence and 
is a novel biomarker of human vascular ag-
ing. Circulation. 2010;121:2200-2210. DOI: 
10.1161/CIRCULATIONAHA.109.902056
38. Muchir A, Bonne G, van der Kool AJ, 
van Meegan M, Baas F, Bolhuis PA, et al. 
Identification of mutations in the gene 
encoding lamins A/C in autosomal domi-
nant limb girdle muscular dystrophy with 
atrioventricular conduction disturbances 
(LGMD18). Hum Mol Genet. 2000;9:1453-
1459. DOI: 10.1093/hmg/9.9.1453
39. De Sandre-Giovannoli A, Chaouch M, 
 Kozlov S, Vallat JM, Tazir M, Kassouri N, et al. 
Homozygous defects in LMNA, encod-
ing lamin A/C nuclear-envelope proteins, 
cause autosomal recessive axonal neurop-
athy in human (Charcot-Marie-Tooth disor-
der type 2) and mouse. Am J Hum Genet. 
2002;70:726-736. DOI: 10.1086/339274
40. Eriksson M, Brown WT, Gordon LB, 
Glynn MW, Singer J, Scott L et al. 
Recurrent de novo point mutations in 
lamin A cause Hutchinson-Gilford progeria 
syndrome. Nature. 2003;423:293-298. DOI: 
10.1038/nature01629
41. Chen L, Lee L, Kudlow BA, Dos Santos HG, 
Sletvold O, Shafeghati Y, et al. LMNA muta-
tions in atypical Werner’s syndrome. Lancet. 
2003;362:440-445. DOI: 10.1016/S0140-
6736(03)14069-X
42. Fatkin D, MacRae C, Sasaki T, Wolff 
MR, Porcu M, Frenneaux M, et al. 
Missense mutations in the rod domain of 
the lamin A/C gene as causes of dilated 
cardiomyopathy and conduction-system 
disease. N Engl J Med. 1999;341:1715-1724. 
DOI: 10.1056/NEJM199912023412302
43. De Sandre-Giovannoli A, Bernard R, Cau P, 
Navarro C, Amiel J, Boccaccio I et al. Lamin 
Malkawi, A. et al.             Lamin A/C expression in AAA
161             Original Research Article
a truncation in Hutchinson-Gilford proge-
ria. Science. 2003;300:2055. DOI: 10.1126/
science.1084125
44. Shackelton S, Lloyd D, Jackson SN, Evans 
R, Niermeijer MF, Singh BM, et al. LMNA, 
encoding Lamin A/C is mutated in partial 
 lipodystrophy. Nat Genet. 2000;24:153-
156. DOI: 10.1038/72807
45. Novelli G, Muchir A, Sangiuolo F, Hel-
bling-Leclerc A, D’Apice MR, Massart C, 
et  al. Mandibuloacral dysplasia is caused 
by a mutation in LMNA-encoding lamin 
A/C. Am J Hum Genet. 2002;71:426-431. 
DOI: 10.1086/341908 
46. Navarro CL, De Sandre-Giovannoli A, Ber-
nard R, Boccaccio I, Boyer A, Geneviève D, et 
al. Lamin A and ZMPSTE24 (FACE-1) defects 
cause nuclear disorganization and identify 
restrictive dermopathy as a lethal neonatal 
laminopathy. Hum Mol Genet. 2004;13:2493-
2503. DOI: 10.1093/hmg/ddh265
47. Huang S, Risques RA, Martin GM, Rabino-
vitch PS, Oshima J. Accelerated telomere 
shortening and replicative senescence in hu-
man fibroblasts overexpressing mutant and 
wild-type lamin A. Exp Cell Res. 2008;314:82-
91. DOI: 10.1016/j.yexcr.2007.08.004
48. Dawson J, Tooze J, Cockerill G, Choke E, Lof-
tus I, Thompson MM. Endothelial progeni-
tor cells and abdominal aortic aneurysms. 
Ann NY Acad Sci. 2006;1085:327-330. DOI: 
10.1196/annals.1383.011
49. Cafueri G, Parodi F, Pistorio A, Bertolotto 
M, Ventura F, Gambini C, et al. Endothelial 
and smooth muscle cells from abdominal 
aortic aneurysm have increased oxida-
tive stress and telomere attrition. PLoS 
One. 2012;7:e35312. DOI: 10.1371/journal.
pone.0035312
50. Thompson RW, Liao S, Curci JA.  Vascular 
smooth muscle cell apoptosis in 
 abdominal aortic aneurysms. Coron Ar-
tery Dis. 1997;8:623-631. DOI: 10.1097/ 
00019501-199710000-00005
51. Torsney E, Pirianov G, Charolidi N, Shore-
im A, Gaze D, Petrova S, et al. Elevation of 
plasma high-density lipoproteins inhibits 
development of experimental abdominal 
aortic aneurysm. Arterioscler Thromb Vasc 
Biol. 2012;32:2678-2686. DOI: 10.1161/AT-
VBAHA.112.00009
52. Lazebnik Y, Takahashi A, Moir R, Goldman 
R, Poiriser G, Kaufmann S, et al. Stud-
ies of lamin proteinase reveal multiple 
parallel biochemical pathways during 
apoptotic execution. Proc Natl Acad Sci 
USA.1995;92:9042-9046. DOI: 10.1073/
pnas.92.20.9042
53. Steen RL, Collas P. Mistargeting of B-type 
lamins at the end of mitosis: implications 
on cell survival and regulation of lamins 
A/C expression. J Cell Biol. 2001;153:621-
626. DOI: 10.1083/jcb.153.3.621
54. Capell BC, Olive M, Erdos MR, Cao K, Fadd-
ah DA, Tavarez UL, et al. A farnesyltransfer-
ase inhibitor prevents both the onset and 
late progression of cardiovascular disease 
in a progeria mouse model. Proc Natl 
Acad Sci USA. 2008;105:15902-15907. DOI: 
10.1073/pnas.0807840105
55. Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, 
et al. Blocking protein farnesyltransferase 
improves nuclear blebbing in mouse fibro-
blasts with a targeted Hutchinson-Gilford 
progeria syndrome mutation. Proc Natl 
Acad Sci USA. 2005;102:10291-10296. DOI: 
10.1073/pnas.0504641102
56. Jeremy RW, Robertson E, Lu Y, Hambly BD. 
Perturbations of mechanotransduction 
and aneurysm formation in heritable aor-
topathies. Int J Cardiol. 2013;169:7-16. DOI: 
10.1016/j.ijcard.2013.08.056
57. Bäck M, Gasser TC, Michel JB, Caligiuri 
G. Biomechanical factors in the biology 
of aortic wall and aortic valve diseases. 
Cardiovasc Res. 2013;99:232-241. DOI: 
10.1093/cvr/cvt040
58. Humphrey JD, Milewicz DM, Tellides 
G, Schwartz MA. Cell biology. Dys-
functional mechanosensing in aneu-
rysms. Science. 2014;344:477-479. DOI: 
10.1126/ science.1253026
Cite this article as:  Malkawi A, Pirianov 
G, Torsney E, Chetter I, Sakalihasan N, 
Loftus IM, Nordon I, Huggins C, Charolidi 
N, Thompson M, Xu XY, Cockerill GW. 
Increased Expression of Lamin A/C 
Correlate with Regions of High Wall 
Stress in Abdominal Aortic Aneurysms. 
AORTA (Stamford). 2015;3(5):152-166. 
DOI: http://dx.doi.org/10.12945/j.
aorta.2015.14.069
AORTA, October 2015            Volume 3, Issue 5:152-166
Original Research Article             162
Supplementary Table 1. Upregulated genes at regions exposed to high stress (2-fold change threshold).
Fold change Symbol Definition / (Chromosomal Location) p value
2.07 TRUB1 TruB pseudouridine (psi) synthase homolog 1 (10) 0.009
2.11 MRC2 Mannose receptor, C Type 2 (17) 0.038
2.26 CA8 Carbonic anhydrase VIII (8) 0.016
2.22 SORBS3 Sorbin and SH3 domain-containing 3 (8) 0.016
2.24 AFAP Actin filament associated protein (4) 0.034
2.29 HSPG2 Heparan sulfate proteoglycan 2 (perlecan) (1) 0.029
2.81 SOCS5 Suppressor of cytokine signaling 5 (2) 0.011
2.05 FLJ45337 FLJ45337 protein (1) 0.042
4.61 TRIM36 Tripartite motif-containing 36 (5) 0.017
2.43 LUZP2 Leucine zipper protein 2 (11) 0.004
3.54 GNAO1 Guanine nucleotide binding protein alpha activating activity O (16) 0.017
2.38 CDKL2 Cyclin-dependent kinase-like 2 (CDC2-related kinase)(4) 0.013
2.06 HEPH Hephaestin (X) 0.015
2.34 PODXL2 Podocalyxin-like 2 (3) 0.028
2.26 LOC654119 Similar to hypothetical protein FLJ10159 0.049
2.09 ADD3 Adducing 3 (gamma) (10) 0.015
2.76 DKK3 Dickkopf homolog 3 (Xenopus laevis) (11) 0.016
2.16 SBDSP Shwachman-Bodian-Diamond syndrome pseudogene (7) 0.006
2.41 MXRA8 Matrix-remodeling associated 8 (1) 0.035
2.03 PPP2R5D Protein phosphatase 2, regulatory subunit B’, delta isoform (6) 0.021
2.27 ISYNA1 Myo-inositol 1-phosphatase synthase A1 (19) 0.038
2.11 CDC42EP5 CDC42 effector protein (Rho GTPase binding) 5 (19) 0.040
2.10 PTPRS Protein tyrosine phosphatase, receptor type, S (19) 0.031
2.01 PDE5A Phosphodiesterase 5A, cGMP-specific (4) 0.032
2.35 CKLFSF4 Chemokine-like factor superfamily 4 (16) 0.047
2.86 VGCNL1 Voltage gated channel like 1 (13) 0.015
2.09 A2ML1 Alpha-2-macroglobulin-like 1 (12) 0.043
2.06 CTBP2 C-terminal binding protein 2 (10) 0.044
3.18 IL17B Interleukin 17B (5) 0.018
3.88 PCDHB11 Protocadherin beta 11 (5) 0.017
2.78 ISLR Immunoglobulin superfamily containing leucine rich repeat (5) 0.007
2.11 MFAP2 Microfibrillar-associated protein 2 (1) 0.038
2.34 ELN Elastin (7) 0.049
3.36 RPRM Reprimo, TP53 dependent G2 arrest mediator candidate (2) 0.022
2.34 PTGER3 Prostaglandin E receptor 3 (1) 0.008
2.06 NUDT10 Nudix (nucleoside diphosphate linked moiety X)-type motif 10 (X) 0.030
2.26 DNAJC4 DnaJ (Hsp40) homolog, subfamily C, member 4 (11) 0.020
Highly significant genes appear in bold.
(table continues)
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Supplementary Table 1. (continued)
Fold change Symbol Definition / (Chromosomal Location) p value
2.40 CD151 CD151 antigen (11) 0.024
2.10 FBLN1 Fibulin 1 (FBLN1), transcript variant C (22) 0.028
2.28 UNQ1940 HWKM1940 (UNQ1940) (7) 0.035
2.41 ARHGAP6 Rho GTPase activating protein 6 (X) 0.019
2.54 KRT7 Keratin 7 (12) 0.019
2.33 TRIM36 Tripartite motif-containing 36 (5) 0048
2.40 GLIS2 GLIS family zinc finger 2 (16) 0.037
2.00 PABPC5 Poly(A) binding protein, cytoplasmic 5 (X) 0.028
2.23 CNTN4 Contactin 4 (3) 0.015
2.13 CYP11A1 Cytochrome P450, family 11, subfamily A, polypeptide 1 (15) 0.038
2.21 KCNMA1 Potassium large conductance calcium-activated channel, subfamily MA1 (10) 0.047
2.15 RGMB RGM domain family, member B (5) 0.037
2.06 ZNF704 Zinc finger protein 704 (8) 0.043
2.38 RND2 Rho family GTPase 2 (17) 0.025
2.42 ADAMTS2 ADAM metallopeptidase with thrombospodin Type 1 motif 2 (5) 0.006
2.55 THSD4 Thrombospondin, Type I, domain containing 4 (15) 0.027
2.91 ANKS1B Ankyrin repeat and sterile alpha motif domain containing 1B (12) 0.012
2.43 LOC653762 PREDICTED: similar to B-cell receptor-associated protein 29 (7) 0.007
2.01 INPP5F Inositol polyphosphate-5-phosphatase F (10) 0.029
2.86 FBXO32 F-box protein 32 (8) 0.009
2.59 MAP6 Microtubule-associated protein 6 (11) 0.033
2.26 PGM5P2 PREDICTED: phosphoglucomutase 5 pseudogene 2 (9) 0.046
2.58 MGC33486 PREDICTED: hypothetical protein MGC33486 0.030
2.54 PDE5A Phosphodiesterase 5A, cGMP-specific (4) 0.045
2.85 MAP1B Microtubule-associated protein 1B (5) 0.036
2.03 TSC22D3 TSC22 domain family, member 3 (X) 0.012
2.01 SCARF2 Scavenger receptor class F, member 2 (22) 0.048
3.85 RTN1 Reticulon 1 (RTN1), transcript variant 3 (14) 0.038
2.41 CILP Cartilage intermediate layer protein, nucleotide pyrophosphohydrolase (15) 0.031
2.34 FGF1 Fibroblast growth factor 1 (acidic) (5) 0.049
2.14 KIAA0773 KIAA0773 gene product(7) 0.017
2.22 LMO3 LIM domain only 3 (rhombotin-like 2) (12) 0.049
2.85 LMNA Lamin A/C (1) 0.0003
Highly significant genes appear in bold.
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Supplementary Table 2. Downregulated genes at regions exposed to high stress (2-fold change threshold).
Fold change Symbol Definition / (Chromosomal Location) p value
2.11 SIGLEC5 Sialic acid binding Ig-like lectin 5 (19) 0.042
2.30 UBASH3A Ubiquitin associated and SH3 domain-containing, A (21) 0.049
4.13 FCAMR Fc receptor, IgA, IgM, high affinity (1) 0.046
2.18 LOC349236 Chromosome 9 open reading frame 164 (9) 0.004
2.11 CYP3A43 Cytochrome P450, family 3, subfamily A, polypeptide 43 (7) 0.001
2.08 TRIM69 Tripartite motif-containing 69 (15) 0.037
2.03 CD80 CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) (3) 0.009
4.04 CHI3L2 Chitinase 3-like 2 (1) 0.034
2.39 OR5B21 Olfactory receptor, family 5, subfamily B, member 21 (11) 0.005
2.24 MARCO Macrophage receptor with collagenous structure (2) 0.023
2.76 LOC158830 Similar to Ab2-183 (X) 0.041
2.25 HGD Homogentisate 1,2-dioxygenase (homogentisate oxidase) (3) 0.021
2.14 TTN Titin (2) 0.009
2.42 DPPA4 Developmental pluripotency associated 4 (3) 0.044
2.11 TAP2 Transporter 2, ATP-binding cassette, sub-family B (6) 0.045
2.05 C7orf16 Chromosome 7 open reading frame 16 (7) 0.031
2.40 TRAF3IP3 TRAF3 interacting protein 3 (1) 0.043
2.24 ELF3 E74-like factor 3 (ets domain transcription factor) (1) 0.034
2.58 TLR10 Toll-like receptor 10 (4) 0.049
2.39 RAB26 RAB26, member RAS oncogene family (16) 0.025
2.43 SCML4 Sex comb on midleg-like4 (Drosophila) (6) 0.034
2.05 SLC12A3 Solute carrier family 12 (sodium/chloride transporters) (16) 0.028
2.13 MCOLN2 Mucolipin 2 (1) 0.022
2.26 ANGPTL6 Angiopoietin-like 6 (19) 0.022
2.38 RAB39B RAB39B, member RAS oncogene family (X) 0.044
4.24 FLJ40919 Hypothetical protein FLJ40919 (13) 0.042
2.28 CPLX3 complexin 3 (15) 0.004
2.77 C6orf105 Chromosome 6 open reading frame 105 (6) 0.016
2.31 RP11-450P7.3 Kelch-like 34 (Drosophila) (X) 0.033
2.11 TRIM14 Tripartite motif-containing 14 (9) 0.047
2.10 MGC40069 Hypothetical protein MGC40069 0.033
2.78 CCL22 Chemokine (C-C motif ) ligand 22 (16) 0.017
2.01 TM7SF2 Transmembrane 7 superfamily member 2 (11) 0.035
2.33 CCL20 Chemokine (C-C motif ) ligand 20 (2) 0.040
2.47 CCR6 Chemokine (C-C motif ) ligand 6 (6) 0.034
Highly significant genes appear in bold.
(table continues)
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Supplementary Table 2. (continued)
Fold change Symbol Definition / (Chromosomal Location) p value
2.05 EMR2 EGF-like module containing, mucin-like hormone rec (19) 0.019
2.83 KIAA1189 KIAA1189 (2) 0.047
2.48 KIR3DL2 Killer cell immunoglobulin-like receptor (19) 0.012
2.05 C9orf128 Chromosome 9 open reading frame 128 (9) 0.048
2.11 ATP2A3 ATPase, Ca++ transporting, ubiquitous (17) 0.048
2.26 ANKRD55 Ankyrin repeat domain 55 (5) 0.046
2.97 TXK TXK tyrosine kinase (4) 0.041
2.75 TMEM16J Transmembrane protein 16J (11) 0.011
2.64 FCRL3 Fc receptor-like 3 (1) 0.009
2.76 KEL Kell blood group, metallo-endopeptidase (7) 0.040
2.07 C20orf174 Chromosome 20 open reading frame 174 (20) 0.042
2.63 CXADR Coxsackie virus and adenovirus receptor (21) 0.044
2.06 FLJ43752 FLJ43752 protein (6) 0.001
2.91 ZAP70 Zeta-chain (TCR) associated protein kinase 70 kDa (2) 0.028
3.03 IBSP Integrin-binding sialoprotein (4) 0.022
2.62 TDO2 Tryptophan 2,3-dioxygenase (4) 0.043
2.78 FCRL3 Fc receptor-like 3 (1) 0.047
2.37 FLJ11795 FLJ11795 protein (5) 0.049
2.33 COL4A3 Collagen, Type IV, alpha 3 (2) 0.033
Highly significant genes appear in bold.
Supplementry Table 3. Gene Ontology for candidate genes identified as differentially expressed in response to high wall stress.
Count1 %
Genes with increased expression
Extracellular region 16 25.0
Cell adhesion 9 14.1 
Extracellular space 8 12.5
Extracellular region & proteinaceous extracellular matrix 7 10.9
Nervous system development 6 9.4 
Cell adhesion & protein binding 5 7.8 
Cell adhesion & integral to plasma membrane 4 6.3
Cell adhesion, membrane & protein binding 4 6.3
Metal ion binding & response to drug 3 4.7
Cell adhesion, membrane, protein binding & integral to plasma membrane 3 4.7
(table continues)
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Supplementary Table 3. (continued)
Count1 %
Genes with decreased expression
Plasma membrane 17 34.0
Receptor activity 10 20.0
Plasma membrane & receptor activity 9 18.0
Extracellular space & extracellular response 6 12.0 
Immune response 5 10.0
Signal transduction, immune response 4 8.0
Protein binding, interspecies interaction between organisms & plasma membrane 3 6.0
Nucleotide binding, plasma membrane, protein transport 3 6.0
Inflammatory response, signal transduction & immune response 3 6.0
Signal transduction, immune response & chemotaxis 3  6.0
1 Number of differentially expressed genes annotated under term. 
2 Percent of differentially expressed genes annotated under term.
